Cite
Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden.
MLA
Cardell, Lars-Olaf, et al. “Modelling the Impact of Sublingual Immunotherapy versus Subcutaneous Immunotherapy on Patient Travel Time and CO2 Emissions in Sweden.” Scientific Reports, vol. 13, no. 1, Jan. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41598-024-51925-8.
APA
Cardell, L.-O., Sterner, T., Ahmed, W., Slættanes, A. K., Svärd, M., & Pollock, R. F. (2024). Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden. Scientific Reports, 13(1), 1–12. https://doi.org/10.1038/s41598-024-51925-8
Chicago
Cardell, Lars-Olaf, Thomas Sterner, Waqas Ahmed, Andreas Kallsoy Slættanes, Mikael Svärd, and Richard F. Pollock. 2024. “Modelling the Impact of Sublingual Immunotherapy versus Subcutaneous Immunotherapy on Patient Travel Time and CO2 Emissions in Sweden.” Scientific Reports 13 (1): 1–12. doi:10.1038/s41598-024-51925-8.